HeyJaredBill Holodnak
- Indexed articles, last 90 days
- 3
- Latest publication
- Sep 16, 2026
- Outlet visibility, for forbes.com
- Top 5K sites
- Earliest in this view
- Jul 15, 2026
Latest articles
Your Biotech Career Is Only As Secure As Your Ability To Keep Learning (opens the original)
Read excerpt
Bill Holodnak, CEO and Founder of Occam Global, an executive search and advisory firm focused on leadership across the innovation economy. For years, the career advice in life sciences was straightforward: If you wanted stability, join a large pharmaceutical company. If you wanted excitement and embraced the risks that came with it, join a biotech startup. But that distinction is becoming increasingly blurred. Large companies may appear more stable, but appearances don’t always reflect reality.
How An Executive Chairman Can Support A First-Time CEO In Biotech (opens the original)
Read excerpt
Bill Holodnak, CEO and Founder of Occam Global, an executive search and advisory firm focused on leadership across the innovation economy. In recent years, I've seen many biotech and high-growth science company boards elevating founder-scientists, M.D.s and Ph.D.s to chief executive roles. These leaders often possess extraordinary scientific insight and develop breakthrough technologies, but many have never managed the operational complexity of building and scaling an enterprise. This is an impo
The Best Careers Are Built On Taking Risk, Not Hedging Your Bets (opens the original)
Read excerpt
Bill Holodnak, CEO and Founder of Occam Global, an executive search and advisory firm focused on leadership across the innovation economy. There’s a persistent belief that career success follows a rational path: work hard, make smart decisions and steadily upward progress. In reality, successful careers are rarely linear. They are shaped by logic, instinct and moments when individuals step outside the predictable and take risks that don’t fully make sense on paper. The question that ambitious pr
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For forbes.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.